Day: December 23, 2024

Ritlecitinib (Litfulo): A New Hope for Severe Alopecia Areata Patients

Discover how Litfulo (ritlecitinib), a newly FDA-approved treatment for severe alopecia areata, offers renewed hope for patients seeking effective hair regrowth solutions.